Clinical Trial Update: Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating pembrolizumab versus observation in people with triple-negative breast cancer who achieved pathologic complete response after …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 3 | Status: RECRUITING